Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 17:56:09 GMT 2023
by
admin
on
Sat Dec 16 17:56:09 GMT 2023
|
Protein Type | MONOCLONAL ANTIBODY |
Protein Sub Type | IGG1 |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
KXG2PJ551I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
L01XC31
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
||
|
NCI_THESAURUS |
C128057
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
||
|
FDA ORPHAN DRUG |
491815
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
||
|
NDF-RT |
N0000193338
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
||
|
FDA ORPHAN DRUG |
604117
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/15/1590
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
KXG2PJ551I
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
PRIMARY | |||
|
5221
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
PRIMARY | |||
|
100000166075
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
PRIMARY | |||
|
SUB180078
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
PRIMARY | |||
|
DE-160
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
PRIMARY | |||
|
1875534
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
PRIMARY | |||
|
1537032-82-8
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
PRIMARY | |||
|
DB11945
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
PRIMARY | |||
|
C116870
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
PRIMARY | |||
|
KXG2PJ551I
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
PRIMARY | |||
|
Avelumab
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
PRIMARY | |||
|
m11986
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
PRIMARY | |||
|
10062
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
PRIMARY | |||
|
Avelumab
Created by
admin on Sat Dec 16 17:56:09 GMT 2023 , Edited by admin on Sat Dec 16 17:56:09 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_22 | 1_96 |
1_147 | 1_203 |
1_264 | 1_324 |
1_370 | 1_428 |
2_22 | 2_96 |
2_147 | 2_203 |
2_264 | 2_324 |
2_370 | 2_428 |
3_22 | 3_90 |
3_138 | 3_197 |
4_22 | 4_90 |
4_138 | 4_197 |
1_223 | 3_215 |
2_223 | 4_215 |
1_229 | 2_229 |
1_232 | 2_232 |
Glycosylation Type | MAMMALIAN |
Glycosylation Link Type | Site |
---|---|
N | 1_300 |
N | 2_300 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Biacore
BINDING
Kd
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|